Hanson & Doremus Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $82K | Sell |
|
|||||
|
2025
Q2 | $108K | Sell |
|
|||||
|
2025
Q1 | $134K | Sell |
|
|||||
|
2024
Q4 | $322K | Sell |
|
|||||
|
2024
Q3 | $487K | Sell |
|
|||||
|
2024
Q2 | $723K | Sell |
|
|||||
|
2024
Q1 | $845K | Sell |
|
|||||
|
2023
Q4 | $1.22M | Sell |
|
|||||
|
2023
Q3 | $1.7M | Sell |
|
|||||
|
2023
Q2 | $1.99M | Buy |
|
|||||
|
2023
Q1 | $1.7M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Buy |
|
|||||
|
2022
Q3 | $1.59M | Buy |
|
|||||
|
2022
Q2 | $1.16M | Buy |
|
|||||
|
2022
Q1 | $1.19M | Buy |
|
|||||
|
2021
Q4 | $1.31M | Buy |
|
|||||
|
2021
Q3 | $1.34M | Buy |
|
|||||
|
2021
Q2 | $957K | Sell |
|
|||||
|
2021
Q1 | $1.27M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Buy |
|
|||||
|
2020
Q3 | $957K | Buy |
|
|||||
|
2020
Q2 | $798K | Sell |
|
|||||
|
2020
Q1 | $559K | Buy |
|
|||||
|
2019
Q4 | $534K | Buy |
|
|||||
|
2019
Q3 | $332K | Buy |
|
|||||
|
2019
Q2 | $11K | Buy |
|